Salarius Pharmaceuticals, Inc.

Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.

SLRX | NDAQ

Overview

Corporate Details

ISIN(s):: US79400X4043 (+1 more)
LEI:
Country:: United States of America
Address:: 2450 HOLCOMBE BLVD, 77021 HOUSTON
Website:: https://salariuspharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for patients with cancer and other diseases with high unmet medical needs. The company's technology aims to correct the dysregulated gene expression that drives disease progression. Its pipeline is built on two primary drug classes: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials for solid and hematologic cancers like leukemias and lymphomas. The company's TPD candidate, SP-3164, is in IND-enabling studies. Following a merger with Decoy Therapeutics, Salarius is also advancing peptide therapeutics for cancer and respiratory viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Salarius Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Salarius Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Salarius Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Psomagen, Inc. A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.	United States of America	950200
Public Policy Holding Company, Inc. Advisory group providing public policy, government relations, and strategic communications services.	United States of America	PPHC.L
Purple Biotech Ltd. Developing cancer therapies to overcome tumor immune evasion and drug resistance.	Israel	PPBT
Qualigen Therapeutics, Inc. A clinical-stage company developing innovative treatments for rare cancers in adults and children.	United States of America	QLGN
QUIA PHARMA AB Develops biobetters by enhancing approved drugs with a patented drug delivery platform.	Sweden	QUIA
QUINSTREET, INC AI-driven marketplaces connecting consumers to brands in finance & home services on a pay-per-result basis.	United States of America	QNST
Qurient Co., Ltd. Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.	South Korea	115180
Rafael Holdings, Inc. Invests in and develops novel therapeutics for cancer and rare diseases.	United States of America	RFL
RaQualia Pharma Inc. An R&D firm discovering novel small molecules for out-licensing to pharma partners.	Japan	4579
Recruit Holdings Co., Ltd. Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.	Japan	6098